Soteria® is a revolutionary new technology that allows patients to take biopharmaceutical drugs, including monoclonal antibodies, as a simple and safe tablet or capsule.


Phloral® is a cutting-edge technology for precise and consistent delivery to the colon. It exploits changes in gastrointestinal pH in combination with the enzymatic activity of the microbiota as independent but complementary release mechanisms to guarantee site-specific release.

Featured News

Intract Awarded Innovate UK Grant to Manufacture an Oral Antibody Formulation Using its Soteria® Technology

Intract’s Phloral® technology rated among top emerging drug delivery technologies

FIN-403 a Phloral® coated microbial therapeutic shows promising clinical results